Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1 
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger 
CDC Monitors 41 Americans After Andes Hantavirus Outbreak on Luxury Cruise Ship 
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal 
The four types of dementia most people don’t know exist 
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks 
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak 
RFK Jr. Spokesman Resigns Over Trump Administration’s Flavored E-Cigarette Policy 
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent 
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern 
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 
This report analyzes the worldwide markets for HIV/AIDS Testing in Thousands (volume) and US$ Thousand (value) by the following Product Segments: HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 42 companies including many key and niche players such as
- Abbott Laboratories, Inc. (US)
- Abbott Molecular, Inc. (US)
- Adaltis S.r.l. (Italy)
- Alere (US)
- Beckman Coulter, Inc. (US)
- bioMérieux SA (France)
- Bio-Rad Laboratories, Inc. (US)
- Calypte Biomedical Corporation (US)
- Chembio Diagnostic Systems, Inc. (US)
- Hologic, Inc. (US)
- Fujirebio Europe N.V. (Belgium)
- MedMira Inc. (Canada)
- OraSure Technologies, Inc. (US)
- Ortho-Clinical Diagnostics, Inc. (US)
- Quest Diagnostics, Inc. (US)
- Roche Diagnostics (Switzerland)
- Siemens Healthcare Diagnostics, Inc. (US)
- Trinity Biotech Plc. (Ireland)
Key Topics Covered:
1. INDUSTRY OVERVIEW
2. GROWTH DRIVERS AND MARKET TRENDS
3. HIV/AIDS STATISTICS
4. HIV/AIDS: UNDERSTANDING THE DISEASE
5. DIAGNOSIS OF HIV/AIDS
6. PRODUCT APPROVALS & LAUNCHES
7. RECENT INDUSTRY ACTIVITY
8. FOCUS ON SELECT GLOBAL PLAYERS
9. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 42 (including Divisions/Subsidiaries - 47)
- The United States (33)
- Canada (2)
- Europe (8)
- - France (2)
- - Italy (2)
- - Rest of Europe (4)
- Asia-Pacific (Excluding Japan) (4)
For more information visit http://www.researchandmarkets.com/research/cq3kt5/hivaids_testing
CONTACT: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Infectious Disease Testing
